Timothy P. Coughlin, Chief Financial Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 3,000 shares at $42.55 ($128K) on 2017-02-03, disclosed to the SEC on 2017-02-06.
Open-market sale of $128k NBIX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.55 | 1,500 | $64K | 50.0% |
| 2 | $42.55 | 1,500 | $64K | 50.0% |
| Total | $42.55 avg | 3,000 | $128K | 100% |
| Filing → |
| NBIX | SELL | 2017-01-12 | $152K | — | Filing → |
| FATE | BUY | 2016-11-28 | $300K | — | Filing → |
| NBIX | SELL | 2016-02-04 | $57K | — | Filing → |